Communication on this first to market product remains a mystery to me.Does anyone have any idea about this 3rd product that has also received a CRL. I can’t recall any descriptive media release about this submission and would think full disclosure rules would come into play on this,maybe just a lucky dip bag of woman’s health products worth $160million.Unbelievable and very sorry I suggested to holders to hang in there.Cant understand how it could possibly be held up for another 6-8 months ,if there wasn’t corruption involved within the US/FDA process I would have to think a quick fix would be possible.The sooner Trump gets put out of business the better,as he recently stated the desire to have US companies solely in control of their own drug approvals and manufacturing unfortunately being an Australian company doesn’t fall into this category.Cant wait to find out on what elements the FDA are unhappy about.
- Forums
- ASX - By Stock
- Ann: Mayne Pharma provides update on Women's Health pipeline
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

Communication on this first to market product remains a mystery...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online